[1]
H. L. Gao, Y. J. Du, Z. Y. Wu, T. Y. Cao, Y. J. Li, and J. Li, “Long-Term Disease-Free Survival After Sorafenib-Combined Chemotherapy for Refractory Metastatic Testicular Germ Cell Tumor: A Five-Year Follow-Up”, J Med Cases, Jan. 2024, doi: 10.14740/jmc5235.